Production (Stage)
Zevra Therapeutics, Inc.
ZVRA
$8.65
$0.080.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -35.74M | -33.23M | -19.93M | -16.62M |
| Total Depreciation and Amortization | 1.65M | 1.65M | 1.62M | 1.56M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.00K | 22.65M | 13.71M | 694.00K | -957.00K |
| Change in Net Operating Assets | -6.84M | -4.81M | -239.00K | -1.44M | -148.00K |
| Cash from Operations | -8.22M | -16.25M | -18.14M | -19.11M | -16.17M |
| Capital Expenditure | -99.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.64M | -5.47M | -31.35M | -129.00K | 14.79M |
| Cash from Investing | 10.54M | -5.47M | -31.35M | -129.00K | 14.79M |
| Total Debt Issued | -- | 0.00 | 0.00 | 60.07M | -- |
| Total Debt Repaid | -372.00K | 0.00 | 0.00 | -43.13M | -- |
| Issuance of Common Stock | 1.98M | 796.00K | 64.77M | 480.00K | 1.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -2.09M | -- |
| Cash from Financing | 1.61M | 796.00K | 64.77M | 15.33M | 1.22M |
| Foreign Exchange rate Adjustments | -372.00K | 671.00K | -491.00K | 319.00K | -45.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.56M | -20.25M | 14.78M | -3.59M | -200.00K |